CD73-IN-9

• Description :

  CD73-IN-9 is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-9 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 2) [1].

• UNSPSC :

  12352005

• Target :

  CD73

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/cd73-in-9.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1NC=C(C(N1)=O)C2=NN3C=NC=C3C([C@H]4C[C@@H]4C(F)F)=C2

• Molecular Formula :

  C14H11F2N5O2

• Molecular Weight :

  319.27

• References & Citations :

  [1]Xuejun Zhang, et al. Pyrimidinedione compound and use thereof. Patent WO2022068929A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2766565-88-0]